References
- Stahnke N. Leukemia in growth-hormone-treated patients: an update. Horm Res. 1992; 38: 56–62
- Shalet S M. Leukemia in children treated with growth hormone. J Pediatr Endocrinol. 1993; 6: 109–111
- Watanabe S, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia in patients treated with growth hormone. Lancet. 1988; 1159
- Watanabe S, Mizuno S, Oshima L-H, Tsunematsu Y, Fujimoto J, Komiyama A. Leukemia and other malignancies among GH users. J Pediatr Endocrinol. 1993; 6: 99–108
- Fradkin J E, Mills J L, Schonberger L B. Risk of leukemia after treatment with pituitary growth hormone. JAMA 1993; 270: 2829–2832
- Blatt J. Growth hormone and leukemia. Pediatr Hematol Oncol. 1993; 10: 3–5
- Levine E G, Bloomfield C D. Leukemia and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure (review). Semin Oncol. 1992; 19: 47–84
- Ellis M, Lishner M. Second malignancies following treatment in non-Hodgkin's lymphoma (review). Leuk Lymphoma. 1993; 9: 337–342
- Estrov Z, Meir R, Barak Y, Zadik Z. Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol. 1991; 9: 394–399